Goldman Sachs is investing $42.5M in Chicago‑based GeoWealth to extend its Series C and deepen a product partnership aimed at RIAs.

Congress moved to restore SBIR/STTR authority, reopening non‑dilutive R&D grants that many New York biotech startups rely on.

New reporting shows Epstein paid consultants and used fake sites and Wikipedia edits to bury negative search results and burnish a philanthropic image.

Pfizer reported mid‑stage results showing atirmociclib plus fulvestrant cut progression or death risk by about 40% in patients previously treated with CDK4/6 inhibitors.

Gracenote sued OpenAI in Manhattan, alleging its curated media metadata was copied to train ChatGPT. The suit says the company's database structure was used without permission.

Perplexity asked a federal judge to narrow parts of suits by The New York Times and Chicago Tribune while leaving core copyright allegations intact.

A small NYU Langone pilot found microplastic fragments in nine of 10 prostate tumors, with tumor tissue holding roughly 2.5 times more plastic than nearby healthy tissue. Researchers call the result surprising but preliminary.

Mount Sinai is rolling out face‑scan check‑ins with CLEAR1 across its hospitals and clinics, promising faster check‑ins and fewer duplicate records while prompting privacy debate.

Hong Kong’s RedotPay is reportedly weighing a New York IPO that could raise more than $1 billion and value the company north of $4 billion as regulators ready licenses. Investors will be watching reserves and redemption rules closely.

Mount Sinai‑affiliated clinics in Manhattan are using an FDA‑cleared AI from BrightHeart to flag fetal heart abnormalities, a move studies show boosts detection and shortens review time.

Nobel laureate Richard Axel stepped down as co‑director of Columbia’s Zuckerman Institute after DOJ records linked him to Jeffrey Epstein. Columbia said it found no evidence of legal violations but accepted his resignation.

SUNY researchers say dim indoor light during close-up work may be driving the rise in nearsightedness and offer simple fixes for parents, schools and commuters.

Jonathan Haidt's book and public push have helped move age-based social media limits from debate into law and school policy. The science is contested and young people want a voice.